Abstract Submission

Abstract review process

An international panel of scientific experts will review the abstracts which may be selected for an oral or poster presentation. The first (presenting) author will receive a confirmation of acceptance for either an oral or poster presentation, or a notice of rejection, by e-mail by the end of September, 2017.

Abstract submission is now closed


1.1 Organisational issues
1.2 Information technology
1.3 Cost/effectiveness
1.4 Training and education
1.5 Risk models, standards and regulation
1.6 Blood supply management and utilization
1.7 Quality management

2.1 Blood donor recruitment
2.2 Blood collection including apheresis
2.3 Donor adverse events

3.1 Blood processing, storage and release
3.2 Blood components
3.3 Plasma products
3.4 Pathogen inactivation
3.5 Novel blood products

4.1 Screening strategies for TTI
4.2 Hepatitis B (HBV)
4.3 Hepatitis C (HCV)
4.4 HIV
4.5 Bacteria
4.6 Parasites
4.7 Newly emerging pathogens and other transfusion related pathogens

5.1 Red cell immunology: Serology
5.2 Red cell immunology: Molecular
5.3 Platelet immunology
5.4 Granulocyte immunology
5.5 Fetal-maternal immunology

6.1 Neonatal and pediatric transfusion
6.2 Therapeutic apheresis
6.3 Evidence based transfusion medicine practice
6.4 Haemorrhage and massive transfusion
6.5 Adverse events, including TRALI
6.6 Haemovigilance and transfusion safety
6.7 Alternatives to blood transfusion

7.1 Stem cell and tissue banking, including cord blood
7.2 Collection, processing, storage and release
7.3 Clinical applications

8.1 HLA in transfusion medicine
8.2 Histocompatibility in stem cell transplantation
8.3 Histocompatibility in organ transplantation



"I see ISBT as a global mosaic where professionals with different backgrounds get connected to create the big picture: enhancing transfusion practice."

So-Yong Kwon, South Korea
Become a member from 55,- euro p/y join us now